2020 | Efficacy and Safety of MT10107 (Coretox) in Poststroke Upper Limb Spasticity Treatment: A Randomized, Double-Blind, Active Drug-Controlled, Multicenter, Phase III Clinical Trial | ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION |
2023 | Efficacy and Safety of Multi-Kinase Inhibitors for Patients with Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer: A Systematic Review and Meta-Analysis
| Thesis |
2015 | Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial | JOURNAL OF THE NEUROLOGICAL SCIENCES |
2020 | Efficacy and Safety of Naftopidil in Patients With Neurogenic Lower Urinary Tract Dysfunction: An 8-Week, Active-Controlled, Stratified-Randomized, Double-Blind, Double-Dummy, Parallel Group, Noninferiority, Multicenter Design
| INTERNATIONAL NEUROUROLOGY JOURNAL |
2020 | Efficacy and Safety of Nerinetide for the Treatment of Acute Ischaemic Stroke (ESCAPE-NA1): A Multicentre, Double-Blind, Randomised Controlled Trial | LANCET |
2021 | Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial
| INTERNATIONAL JOURNAL OF OPHTHALMOLOGY |
2017 | Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria
| JOURNAL OF DERMATOLOGICAL SCIENCE |
2020 | Efficacy and Safety of Omega-3 Fatty Acids in Patients Treated With Statins for Residual Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
| DIABETES & METABOLISM JOURNAL |
2022 | Efficacy and safety of onabotulinumtoxinA with standardized physiotherapy for the treatment of pediatric lower limb spasticity: A randomized, placebo-controlled, phase III clinical trial
| NEUROREHABILITATION |
2024 | Efficacy and Safety of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin as Metformin Add-on in a Korean Population with Type 2 Diabetes
| DIABETES THERAPY |
2008 | Efficacy and safety of oral SK3530 for the treatment of erectile dysfunction in Korean men: a multicenter, randomized, double-blind, placebo-controlled, fixed dose, parallel group clinical trial.
| ASIAN JOURNAL OF ANDROLOGY |
2020 | Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase | LANCET DIABETES & ENDOCRINOLOGY |
2020 | Efficacy and Safety of Outpatient Clinic-based Elective External Electrical Cardioversion in Patients with Atrial Fibrillation
| KOREAN CIRCULATION JOURNAL |
2023 | Efficacy and safety of P2Y12 inhibitor monotherapy after complex PCI: a collaborative systematic review and meta-analysis | EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY |
2021 | Efficacy and safety of palliative endobiliary radiofrequency ablation using a novel temperature-controlled catheter for malignant biliary stricture: a single-center prospective randomized phase II TRIAL | SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES |
2015 | Efficacy and safety of pegylated interferon base treatment in patients with chronic hepatitis C on dialysis | EUROPEAN JOURNAL OF INTERNAL MEDICINE |
2022 | Efficacy and safety of pembrolizumab (pembro) monotherapy in East Asian patients (pts) with urothelial carcinoma (UC) in KEYNOTE-045 or KEYNOTE-052 | ANNALS OF ONCOLOGY |
2020 | Efficacy and Safety of Pembrolizumab for Gemcitabine/Cisplatin-Refractory Biliary Tract Cancer: A Multicenter Retrospective Study
| JOURNAL OF CLINICAL MEDICINE |
2020 | Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE-158 and KEYNOTE-028 studies | INTERNATIONAL JOURNAL OF CANCER |
2019 | Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study | JOURNAL OF CLINICAL ONCOLOGY |